LOS ANGELES, June 9, 2025 /PRNewswire/ -- TORL BioTherapeutics LLC (TORL), a clinical-stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

Federal regulators have authorized hundreds of drugs without evidence they work, and many are dangerous.